A new form of S-ketamine in treatment of depression

Depression is among the most common mental disorders in the world and one of the greatest challenges in treatment of this condition is drug-resistant depression. In recent years, it has been shown that ketamine, a known analgesic and anesthetic, is also a strong anti-depressant. A solution currently developed in Celon Pharma laboratories is an innovative route of administration (other than intravenous) of the active substance–S-ketamine. Such a solution will allow for a wider use of the therapy in patients suffering from depression and bipolar disorder and will significantly improve their comfort of lives.